VBI Vaccines (acquired by SciVac Therapeutics)

VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI's eVLP vaccine platform allows for the design of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus. The company's lead eVLP asset is a prophylactic cytomegalovirus ("CMV") vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company's sec...Show all

VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI's eVLP vaccine platform allows for the design of enveloped ("e") virus-like particle ("VLP") vaccines t...Show all

See All Exits Recent Exits

Phone: 617-830-3031

Fax:

222 Third Street
Suite 2241
Cambridge, 02142
Massachusetts, United States

VBI Vaccines (acquired by SciVac Therapeutics) - Investments & Acquisitions

Show Real Data VBI Vaccines (acquired by SciVac Therapeutics) Investments
See all Recent Investments
Date Company Round Amount Co-investors
2011-09-19EpixisAcquired
See all 1 investments